article thumbnail

Insurance companies putting profits ahead of patients

World of DTC Marketing

Five of America’s largest health insurers reported more than $11bn in profits in the second quarter – a decline from the same period last year when the Covid-19 pandemic helped drive sky-high profits yet they are having more of a say on patients’ treatments even when HCPs disagree. Then there is prior authorization.

Insurance 225
article thumbnail

Should doctors refuse to treat obese patients?

World of DTC Marketing

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. Susan knew she needed to lose weight, especially when her doctor told her that her A1C indicated that she was prediabetic.

Doctors 250
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our abysmal health care system

World of DTC Marketing

First, the health insurance companies are making a lot of money while burying doctors in paperwork and limiting treatment options. The insurance companies get to dictate medical care and go out of their way to deny medications, surgery, or treatments with no repercussions. Prior authorization is out of control. The result:?

Insurance 263
article thumbnail

Pharma and insurers raking in the cash

World of DTC Marketing

HEY NOW : Most companies struggled in the second quarter as the coronavirus pandemic froze the economy, but health insurers like UnitedHealth heavily benefited as people held off on going to the doctor or hospital, resulting in fewer medical claims that needed to be paid. In addition, pharma profit margins remain very high.

Insurance 119
article thumbnail

Are new weight loss drugs an answer or problem?

World of DTC Marketing

But before the company can make Wegovy mainstream, it has to convince doctors to prescribe it and insurers and governments to pay for it. Wegovy’s monthly list price in the US is about $1,350, and some insurers are not yet covering the drug. Some 80 million obese Americans do not have insurers who will pay for Wegovy.

article thumbnail

Novo’s obesity drug has serious warnings and barriers to overcome

World of DTC Marketing

Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost? Meanwhile, a 2020 study found Medicaid beneficiaries were 27% more likely to have obesity than those who had commercial insurance. . appeared first on World of DTC Marketing.com.

article thumbnail

When it comes to telehealth it’s not numbers

World of DTC Marketing

Today, with that infection risk easing for those who have been vaccinated, many patients nevertheless prefer that doctors, nurses, and other health workers be able to examine and talk to them in person. Of those, 82% reported satisfaction, yet nearly two-thirds — 64% — would have preferred to see their nurse or doctor in person.

Doctors 247